Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 10, 2025 • 3:21 PM ET

Date/Time Source News Release
06/06/2025 09:37 AM EDT GlobeNewswire Soligenix Highlights Dr. Ellen Kim's Recent Q&A and the Promise of HyBryte(TM) in Ongoing Clinical Trials
05/09/2025 07:30 AM EDT PR Newswire Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results
05/07/2025 08:00 AM EDT GlobeNewswire IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Christopher Schaber, CEO of Soligenix Inc.
04/14/2025 07:30 AM EDT PR Newswire Positive Outcome in 75% of CTCL Patients Treated with HyBryte(TM) for 18 Weeks
03/25/2025 08:30 AM EDT GlobeNewswire IBN Initiates Coverage of Soligenix Inc.
03/25/2025 07:30 AM EDT PR Newswire Soligenix Announces Publication Demonstrating CiVax(TM) Booster Induces Rapid Broad Protection Against COVID-19 Variants
03/21/2025 07:30 AM EDT PR Newswire Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results
03/06/2025 07:30 AM EST PR Newswire HyBryte(TM) Treatment Studies Presented at Two Medical Conferences in March
02/04/2025 07:30 AM EST PR Newswire Soligenix to Present at BIO CEO & Investor Conference
01/16/2025 07:30 AM EST PR Newswire Soligenix to Present at Upcoming Investor Conferences
Page

Additional News

As of June 10, 2025 • 3:21 PM ET

Date/Time Source News Release
06/06/2025 10:35 AM EDT BioMedWire Soligenix Inc. (NASDAQ: SNGX) Offers Hope on the Horizon with HyBryte(TM) Treatment Targeting CTCL
06/05/2025 10:05 AM EDT BioMedWire Therapeutic Target Shows Promise in Preventing Cancer Resulting from Chronic Gut Inflammation
06/04/2025 09:00 AM EDT BioMedWire BioMedNewsBreaks - Soligenix Inc. (SNGX) Highlights HyBryte Progress in CTCL via New Podcast Featuring Dr. Ellen Kim
05/27/2025 10:05 AM EDT BioMedWire New Swallowable Pill Provides Real-Time Gut Inflammation Tracking
05/23/2025 11:20 AM EDT BioMedWire Soligenix Inc. (NASDAQ: SNGX) Innovative Treatment to Combat Bacterial Infection Fills Urgent Need for Alternatives to Antibiotics
05/22/2025 03:36 PM EDT BioMedWire BioMedNewsBreaks - Soligenix Inc.'s (NASDAQ: SNGX) HyBryte(TM) Delivers Strong Results in Rare Cancer Trial
05/19/2025 09:50 AM EDT BioMedWire Soligenix Inc. (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results
05/15/2025 12:56 PM EDT BioMedWire BioMedNewsBreaks - Zacks Research Issues Business Update as Soligenix Inc. (NASDAQ: SNGX) Continues Enrollment in Confirmatory Phase 3 HyBryte Trial
05/13/2025 10:05 AM EDT BioMedWire Study Links Higher Consumption of Ultra-Processed Foods to Heightened Psoriasis Risk
05/10/2025 05:31 AM EDT US Earnings Reports Expected earnings - Soligenix Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.